UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses
mitochondrial carrier
Male
uncoupling protein 2
QH301-705.5
Carcinogenesis
Colon
[SDV]Life Sciences [q-bio]
[SDV.CAN]Life Sciences [q-bio]/Cancer
colorectal cancer
Article
Mice
03 medical and health sciences
Intestine, Small
tumor metabolic reprogramming
oxidative stress
lipid synthesis
Animals
Humans
Uncoupling Protein 2
Biology (General)
Aged
Aged, 80 and over
0303 health sciences
Lipogenesis
Middle Aged
mitochondria
[SDV] Life Sciences [q-bio]
Mice, Inbred C57BL
Oxidative Stress
tumor metabolism
Colorectal Neoplasms
Glycolysis
NADP
DOI:
10.1016/j.celrep.2019.07.097
Publication Date:
2019-08-27T14:34:21Z
AUTHORS (12)
ABSTRACT
Colorectal cancer (CRC) is associated with metabolic and redox perturbation. The mitochondrial transporter uncoupling protein 2 (UCP2) controls cell proliferation in vitro through the modulation of cellular metabolism, but underlying mechanism tumors vivo remains unexplored. Using murine intestinal models CRC patient samples, we find higher UCP2 levels compared to their non-tumoral counterparts. We reveal tumor-suppressive role as its deletion enhances colon small tumorigenesis AOM/DSS-treated ApcMin/+ mice, respectively, correlates poor survival latter model. Mechanistically, loss increases oxidized glutathione proteins tumors. deficiency alters glycolytic pathways while promoting phospholipid synthesis, thereby limiting availability NADPH for buffering oxidative stress. show that renders cells more prone malignant transformation reprogramming perturbation homeostasis could favor worse outcomes CRC.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (56)
CITATIONS (36)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....